Home

Noninvasive Tests for Liver Fibrosis

Getting to Grips With the Basics CME

Tuesday, July 1, 2025 | 12:00 PM - 12:30 PM TZ

Supported by an independent educational grant from Siemens Healthineers.

overview

Join us for this informative webinar to explore the role of noninvasive tests (NITs) in identifying patients with metabolic dysfunction-associated steatohepatitis (MASH). Learn how to effectively implement NIT strategies to assess for fibrosis and help ensure that at-risk patients receive timely and appropriate care.

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

MODERATOR

Alina Allen, MD, MS

Associate Professor of Medicine

Mayo Clinic College of Medicine and Science

Rochester, Minnesota

PANELIST

Naim Alkhouri, MD, FAASLD

Chief Medical Officer

Director

Steatotic Liver Program

Arizona Liver Health

Phoenix, Arizona

PANELIST

Neil Skolnik, MD

Professor of Family and Community Medicine

Sidney Kimmel Medical College

Thomas Jefferson University

Associate Director

Family Medicine Residency Program

Abington Jefferson Health

Abington, Pennsylvania

AGENDA

12:00 PM TZ

Welcome and Introduction

12:02 PM TZ

Prevalence of MAFLD/MASH in General Population and the Significance of Fibrosis in MASH

12:07 PM TZ

Types of Noninvasive Tests

12:10 PM TZ

Serum Biomarkers

12:12 PM TZ

Assessment of Liver Stiffness

12:15 PM TZ

Guideline Recommendations on Screening for Fibrosis in Primary Care Settings

12:20 PM TZ

Noninvasive Tests for Risk Stratification and Early Referral Pathways in Primary Care

12:23 PM TZ

Audience Q&A

12:28 PM TZ

Conclusion

Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.

*Video encouraged*

LOCATION

, Online, ,

TARGET AUDIENCE

This educational activity is intended for an audience of hepatologists, gastroenterologists, primary care physicians and nurses in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to understand the basics of NITs to assess liver fibrosis.

LEARNING OBJECTIVES

Upon completion of this activity, participants will:

Have increased knowledge regarding the

Types of NITs for the assessment of fibrosis in MASH
Use of NITs in primary care for the assessment of fibrosis

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.